New Stock News | Zhejiang Rongtai Electric Material (603119.SH) submits application to Hong Kong Stock Exchange
According to the disclosure by the Hong Kong Stock Exchange on January 29th, Zhejiang Rongtai Electrical Equipment Co., Ltd. has submitted its application to list on the main board of the Hong Kong Stock Exchange, with Citic Securities as the exclusive sponsor.
According to the disclosure on January 29 by the Hong Kong Stock Exchange, Zhejiang Rongtai Electric Material Co., Ltd. (referred to as Zhejiang Rongtai Electric Material (603119.SH)) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CITIC SEC as the sole sponsor. The prospectus shows that Zhejiang Rongtai Electric Material is a pioneer and leader in the global new energy mica composite materials and related products, and has become a major supplier of high-performance mica composite materials and related products in the new energy field. With its interdisciplinary expertise in precision processing technology, as well as close ties to customer needs, the company has successfully expanded its business from the mica products field to the key precision structural components field of Siasun Robot&Automation.
According to Frost & Sullivan's data, based on 2024 operating revenue, Zhejiang Rongtai Electric Material ranks first in the global new energy mica products market with a market share of 22.6%; it also ranks first in the Chinese market with a market share of 14.1%. Looking ahead, as policies and safety standards continue to tighten, and downstream industries place increasing emphasis on safety, along with continuous improvements in product performance and technology, mica products are able to meet a wider range of application needs. Therefore, the application scenarios of mica products in the field of new energy vehicles are expected to further expand, thereby continuously releasing market space.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


